而平滑肌细胞凋亡与动脉粥样硬化和血管成形术后再狭窄密切相关。
The apoptosis of smooth muscle cells was related to the atherosclerosis and restenosis of vessels.
血管成形术后发生再狭窄影响手术的远期疗效。
Restenosis after angioplasty influences the long dated surgical effect.
血管介入术后的再狭窄严重影响术后远期疗效。
Restenosis after vascular intervention influences the long term curative effect seriously.
血管平滑肌细胞过度增殖及游移所致的血管内膜增生是血管成形术后再狭窄的重要原因之一。
The major complication of vascular recanalization is intimal hyperplasia which in duc mainly to over-proliferation and migration of smooth muscle cells (SMC).
本文综述了声动力疗法在肿瘤治疗、血管成形术后再狭窄等增殖性疾病方面的医学应用及相应的生物学机制。
This paper reviews the medical application of sonodynamic therapy in the treatment of tumor and restenosis after percutaneous transcoronary angioplasty and the corresponding biomechanism.
结论颈动脉内膜切除术后超声和血管造影联合应用可动态监测早期再狭窄过程，对临床评估有重要意义。
Conclusions Ultrasound combined with angiography are suitable for monitoring the procedure of restenosis after CEA and important for clinical assessment.
目的观察中药对冠心病支架术后缺血心肌血管新生以及支架再狭窄的临床疗效。
ObjectiveTo observe the effect of Tongxinfang on coronary collateral formation and stent-restenosis in patients with coronary artery disease after stenting.
方法总计67只新西兰兔接受了经股动脉途径行球囊损伤腹主动脉术，术后4周处死兔，观察血管再狭窄模型制作情况。
Methods 67 New Zealand rabbits injured by dilated balloon underwent abdominal aortic operation. They were killed after 4th weeks and observed vascular stenosis model.
血管成形术是治疗血管闭塞性疾病的主要手段，但术后再狭窄的高发生率为其的应用带来了阻碍。
Angioplasty is the main method of treating vascular occlusive diseases, but high incidence of restenosis after operation has hampered its clinical applications.
术后靶血管管腔再狭窄是冠状动脉介入治疗术的主要并发症，如何有效预防再狭窄已成为目前介入心脏医学界的主要课题之一。
The in-stent restenosis is one of the main complications in coronary artherosclerotic heart disease patients after PTCA and PCI.
冠心病危险因素、血管造影下冠状动脉病变特征、支架术操作技术参数是影响冠脉病变支架术后再狭窄的主要危险因子。
The risk factors of coronary artery disease, angiographic and procedural features are the main risk factors of restenosis after coronary artery stent implantation.
结论 女性、既往CABG病史、CTO病变、血管直径、置入支架长度是支架术后再狭窄的危险因素，而糖尿病史等与再狭窄无关。
ConclusionFemale, CABG history, CTO lesion, vessel size and length of stent are associated with followup restenosis, while traditional risk factors such as diabetes mellitus have no impact on ISR.
路移植管搭桥术后，常会产生血管再狭窄，导致手术失败。
Restenosis always occurs in coronary artery bypass graft and results in the surgery failure.
药物治疗是减少冠心病介入术后支架内再狭窄、降低远期主要心血管事件的主要手段。
Medicine treatment plays key role in reducing the rate of restenosis and major adverse cardiac events.
术后6个月重复冠状动脉造影，比较两组间的晚期管腔丢失、支架再狭窄率及术后心血管不良事件发生率。
Coronary angiography was performed at the 6th month. The late lumen loss, stent restenosis and major adverse cardiac events were compared in both groups.
目的血管腔内支架成形术目前已被证明是治疗外周动脉硬化闭塞症（PAOD）的有效方法，然而术后出现的再狭窄影响了支架成形术的疗效。
Objective:It is proved that Percutaneous Transluminal Angioplasty and Stenting is a effective treatment of PAOD, but its benefits is seriosly limited by local thrombotic occlusion and restenosis.
目的血管腔内支架成形术目前已被证明是治疗外周动脉硬化闭塞症（PAOD）的有效方法，然而术后出现的再狭窄影响了支架成形术的疗效。
Objective:It is proved that Percutaneous Transluminal Angioplasty and Stenting is a effective treatment of PAOD, but its benefits is seriosly limited by local thrombotic occlusion and restenosis.
应用推荐